AboutContact usRSS
dotsbydots
SEARCHCONTACT US

Buzz

Most popular

Daily
Weekly
1
Stars over Athens: The who’s who at Calcalist's first Israel-Greece conference
2
Wiz acquires Dazz for $450 million to strengthen AI-driven cloud security
3
Cyera doubles valuation to $3B with $300M Series D, total funding hits $600M in seven months
4
Mediaocean acquires Innovid for $500M, delisting it from the NYSE
5
Oracle CEO: "If we continue on our current trajectory, reaching a valuation of a trillion dollars is inevitable"
More news

Teva

20 stories about Teva
קאר שולץ מנכל טבע

Teva Trending Down Following Underwhelming Second Quarter Revenues

02.08.18|Dror Reich
On Thursday, the generic drugmaker announced revenues that fell slightly short of analyst consensus
ועידת לונדון 2017 פרי דוידסון מייסד ו מנכל סייד מדיקל

Plants Are the Future of Medicine, Says Syqe Medical Founder

29.07.18|KPMG, a CTech partner
Transforming cannabis into precisely-dosed treatment has made it medically and financially legitimacy, says Perry Davidson, the founder of Syqe Medical, which developed a precise cannabis inhaler
אלרגן משרדים

Court Rules Allergan Can't Use Indian Tribe Deal to Protect Patents

23.07.18|CTech
In September 2017, Allergan transferred six of its patents for blockbuster dry eye drug Restasis to the St. Regis Mohawk Tribe, hoping to protect the patents under the principle of sovereign immunity
הפגנה הפגנת מחאת ה להט"ב חוק ה פונדקאות עזריאלי 3

Apple Hops on LGBT Support Wagon in Israel

22.07.18|Lilach Baumer
Crowds are currently marching in several Israeli cities, including Tel Aviv and Jerusalem, in protest of ongoing government discrimination against the LGBT community
ה מטה הנוכחי של טבע ב ארה"ב

Mylan Cuts Price of Generic Copaxone Offering by 60%

11.07.18|Lilach Baumer
Mylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800
קאר שולץ מנכל טבע

Teva to Relocate U.S. Headquarters to New Jersey

08.07.18|Lilach Baumer
In December, the Israeli drugmaker announced a far-reaching cost cutting plan to deal with its multi-billion debt
קאר שולץ מנכל טבע

Goldman Sachs Sees 16% Upside in Teva Stock

26.06.18|Dror Reich
Following a meeting with Teva’s management, the bank's analysts reiterated their "buy" recommendation with a higher target price
הפרות סדר עימותים ב גבול רצועת עזה גדר

CTech’s Weekly Roundup of Israeli Tech News

18.05.18|CTech
Israeli-made UAV dumps skunk-water on Gaza protesters. Homegrown content distribution company boosted the Israeli song ahead of Eurovision final.
מפעל טבע קריית שמונה

CTech’s Wednesday Roundup of Israeli Tech News

16.05.18|CTech
Credit Suisse to invest $250 Million in Israel-based life sciences venture fund aMoon. Mercedes to test autonomous electric sedan in Israel
וורן באפט אסיפת בעלי המניות מאי 2018

Berkshire Hathaway Solidified its Teva Position in 2018 First Quarter

16.05.18|Lilach Baumer
According to a Tuesday filing, Berkshire Hathaway more than doubled its Teva stake during the first quarter of 2018
מטה טבע פתח תקווה

Building on Strong First Quarter, Teva Raises 2018 Outlook

03.05.18|Lilach Baumer and Dror Reich
The company reported a 10% decrease in revenues compared to 2017, largely due to North American Copaxone troubles, but beat analyst expectations
default image

Pharma Company Opko Health Retracts Decision to Delist From the Tel Aviv Stock Exchange

29.04.18|Racheli Bindman
Dually listed on Nasdaq and TASE, Opko first submitted a request to delist from the TASE in early April
default image

CTech’s Weekly Roundup of Israeli Tech News

27.04.18|CTech
Printing the perfect burger from cellulose. The challenges of living on Mars. Japanese Prime Minister Shinzo Abe to Visit Israel
שינזו אבה ראש ממשלת יפן

CTech’s Thursday Roundup of Israeli Tech News

26.04.18|CTech
Biotech firm Eloxx plans $50 million in a public offering on Nasdaq, Teva sees three board members depart amid the company’s ongoing revamp, and new data downplays potential benefit of medical marijuana exports
מוסף 16.5 הון אנושי סול ג'יי בארר Sol J. Barer

Three Board Members to Leave Distraught Drugmaker Teva

26.04.18|Lilach Baumer and Dror Reich
Teva, one of the world's largest generic drugmakers, has faced increasing difficulties the past two years
מטה טבע פתח תקווה

Teva Blocked From Launching Generic Version of Israeli Sleep Medicine Circadin

17.04.18|Zohar Shahar Levy and Dror Reich
An Israeli court issued a temporary injunction against Teva, following a lawsuit by the brand drug's maker Neurim Pharmaceuticals
אדם נוימן מעצב חללים ל עבודה ב ניו יורק

CTech’s Tuesday Roundup of Israeli Tech News

10.04.18|CTech
Palo Alto Networks to acquire cybersecurity startup Secdo. WeWork scuttles plans to raise funds in Israel. Medtronic acquires medical visualization company Visionsense for $65 million
מפעל טבע נתניה

Teva and Rimsa Settle Contested $2.3-Billion Acquisition Deal Out of Court

10.04.18|Dror Reich
Teva acquired the Mexican plant in 2016 but shut it down immediately, citing discrepancies between Rimsa's regulatory filing and the actual assets, and filed a suit against the former owners
הפגנה מפגינים פיטורים טבע אשדוד

With No Buyers, Teva to Close Israeli Medical Equipment Plant

09.04.18|Dror Reich
The facility in Ashdod is one of five Teva intends to sell or close in its home country
אדם נוימן ברקע הוסטל של סלינה

CTech’s Weekly Israeli Tech News Roundup

16.03.18|CTech
Israeli defense contractor Elbit to buy state-owned weapons manufacturer IMI, maker of the Uzi submachine gun. WeWork’s offer to Israeli investors: buy bonds and get stock options. Chinese telecommunications company Huawei sued for $23 million by Israeli distributor Electra for breach of contract.
Previous ArticlesMore Articles